Goldman Sachs’s Advantest Corp ATE Stock Holding History

Goldman Sachs’s Portfolio ATE Stock Details ATE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-10,871	Closed	-$127K	–	6912
2013 Q3	$127K	Sell	10,871 -6,170	-36%	-$84.3K	﹤0.01%	6085
2013 Q2	$279K	Buy	+17,041	New	+$263K	﹤0.01%	5365

Other funds holding ATE

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Aperio Group Sausalito, California $33.8B AUM 31.46% 1-Year Est. Return

WAM

World Asset Management Detroit, Michigan $1.01B AUM 42.4% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Goldman Sachs's ATE Position: Q4 2013 in Review

Goldman Sachs sold out of Advantest Corp (ATE) in Q4 2013, closing a stake of 10,871 shares — an estimated $127K sold.

Goldman Sachs first reported a position in ATE in Q2 2013 and held it in 2 quarters. The position peaked at $279K in Q2 2013. 18 funds tracked by Wall St. Rank hold ATE as of Q4 2013.

Goldman Sachs reported no remaining Advantest Corp position as of Q4 2013 after selling out during the quarter.
Goldman Sachs sold 10,871 Advantest Corp shares in Q4 2013, an estimated $127K.
Goldman Sachs first reported a position in Advantest Corp in Q2 2013 and held it in 2 quarters.
Goldman Sachs's Advantest Corp position peaked at $279K in Q2 2013.
18 funds tracked by Wall St. Rank held Advantest Corp as of Q4 2013.

Based on Goldman Sachs's 13F filing for Q4 2013, filed 14 Feb 2014.